Rick Doblin, Ph.D., is the Founder in 1986 and President of the Multidisciplinary Association for Psychedelic Studies (MAPS), a nonprofit that wholly owns its pharmaceutical arm, MAPS Public Benefit Corporation (PBC), which has completed two highly successful Phase 3 studies of MDMA-assisted therapy for PTSD. MAPS PBC stands at a crossroads between obtaining the additional resources it needs from philanthropy, ensuring public benefit is foremost, or becoming a publicly traded company.
BetaSeries est l’application de référence pour les fans de séries qui regardent les plateformes de streaming. Téléchargez l’application gratuitement, renseignez les séries que vous aimez, et recevez instantanément les meilleures recommandations du moment.
© 2024 BetaSeries - Tout contenu externe demeure la propriété du détenteur légitime des droits.